Your browser doesn't support javascript.
loading
Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results.
Shapiro, Amy D; Angchaisuksiri, Pantep; Astermark, Jan; Benson, Gary; Castaman, Giancarlo; Chowdary, Pratima; Eichler, Hermann; Jiménez-Yuste, Victor; Kavakli, Kaan; Matsushita, Tadashi; Poulsen, Lone Hvitfeldt; Wheeler, Allison P; Young, Guy; Zupancic-Salek, Silva; Oldenburg, Johannes.
Affiliation
  • Shapiro AD; Indiana Hemophilia and Thrombosis Center, Indianapolis, IN.
  • Angchaisuksiri P; Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Astermark J; Center for Thrombosis and Haemostasis, Lund University, Skåne University Hospital, Malmö, Sweden.
  • Benson G; Department of Hematology, Belfast Health and Social Care Trust, Belfast, United Kingdom.
  • Castaman G; Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy.
  • Chowdary P; Katharine Dormandy Hemophilia Centre and Thrombosis Unit, Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Eichler H; Institute of Clinical Hemostaseology and Transfusion Medicine, Saarland University and University Hospital, Homburg, Saar, Germany.
  • Jiménez-Yuste V; Haematology Department, La Paz University Hospital, Universidad Autónoma Madrid, Madrid, Spain.
  • Kavakli K; Department of Hematology, Ege University Children's Hospital, Izmir, Turkey.
  • Matsushita T; Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Poulsen LH; The Hemophilia Centre, Department of Haematology, Aarhus University, Aarhus, Denmark.
  • Wheeler AP; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN.
  • Young G; Hemostasis and Thrombosis Center, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA.
  • Zupancic-Salek S; Department of Haematology, and Haemophilia and Thrombosis Unit, University Hospital Centre Zagreb, Zagreb, Croatia.
  • Oldenburg J; School of Medicine, University of Osijek, Osijek, Croatia.
Blood ; 134(22): 1973-1982, 2019 11 28.
Article in En | MEDLINE | ID: mdl-31444162
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hemophilia B / Blood Coagulation Factor Inhibitors / Antibodies, Monoclonal, Humanized / Hemophilia A / Hemorrhage Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2019 Type: Article Affiliation country: India
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hemophilia B / Blood Coagulation Factor Inhibitors / Antibodies, Monoclonal, Humanized / Hemophilia A / Hemorrhage Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2019 Type: Article Affiliation country: India